Publication | Open Access
Efficacy of combined CDK9/BET inhibition in preclinical models of MLL-rearranged acute leukemia
27
Citations
17
References
2020
Year
Mixed-phenotype Acute LeukemiaImmunologyTumor BiologyMyeloid NeoplasiaHematological MalignancyCombined Cdk9/bet InhibitionOncologyMll-rearranged LeukemiaCombined TherapyHematologyRadiation OncologyCancer ResearchHealth SciencesPreclinical ModelsMll-rearranged Acute LeukemiaCell BiologyExtraterminal InhibitorsMalignant Blood DisorderAdult T-cell Leukemia-lymphomaMedicine
Key Points Cyclin-dependent kinase 9 and bromodomain and extraterminal inhibitors are synergistic in MLL-rearranged leukemia. Multiple AML driver genes are downregulated by the combined therapy suggesting broad applicability for this subtype.
| Year | Citations | |
|---|---|---|
Page 1
Page 1